Parameter | Control group | GDT group | p |
---|---|---|---|
Intervention | |||
Crystalloid (ml) | 960 ± 335 | 930 ± 221 | 0.39 |
Colloid (ml) | 1,204 ± 898 | 1,907 ± 878 | <0.0001 |
Blood (ml) | 0 (0–485) | 125 (0–734) | 0.10 |
Dopexamine (μg kg-1 min-1) | 0.0 (0.0–0.0) | 0.75 (0.5–1.0) | <0.0001 |
Change in variable | |||
DO2I (ml min-1 m-2) | -10 ± 190 | +163 ± 249 | 0.0001 |
Stroke volume (ml) | -7.2 ± 28.7 | +6.7 ± 26.1 | 0.01 |
CVP (mmHg) | -1.6 ± 6.8 | -2.1 ± 5.4 | 0.69 |
Serum lactate (mmol l-1) | -0.6 ± 1.1 | -0.3 ± 0.8 | 0.11 |